🇺🇸 FDA
Patent

US 12370188

Formulations of dazucorilant, a glucocorticoid receptor modulator

granted A61KA61K31/4745A61K47/10

Quick answer

US patent 12370188 (Formulations of dazucorilant, a glucocorticoid receptor modulator) held by Corcept Therapeutics Incorporated expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4745, A61K47/10, A61K47/22, A61K9/4825